Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

HHS Secretary Price doesn’t rule out Medicare changes

HHS Secretary Tom Price said the Trump administration and Republicans “believe in the guarantee of Medicare for our seniors,” but he wouldn’t promise there would be no cuts to the program in an interview on CBS's “Face the Nation.”

Reducing costs may take more than focusing on high-cost patients

While a large chunk of healthcare spending may be concentrated among a small population of high-cost patients, focusing on those patients in order to cut down on wasteful spending may not work.

Thumbnail

New IT company from McKesson, Change will focus on value-based care

McKesson Technology Solutions has merged with Change Healthcare, retaining the latter’s name for a new IT company aimed at helping payers, providers and customers “as they strive to achieve the best healthcare outcomes as efficiently as possible in this new environment.” 

Thumbnail

McKesson, Change Healthcare finalize new IT company

The creation of a new data and analytics company, combining McKesson’s technology solutions unit with Nashville, Tenn.-based Change Healthcare, has been completed. The merger unites “the majority” of McKesson Technology Solutions with substantially all of Change, with the new company retaining the Change Healthcare name and Neil de Crescenzo as CEO.

Thumbnail

ACA’s future hot topic at HIMSS 2017—but HIMSS itself doesn’t take a stance

Many panels at HIMSS 2017 in Orlando included references to the ongoing policy debate over the Affordable Care Act (ACA) and how that’s affecting all corners of the industry. For HIMSS itself, however, it feels health IT is better off staying out of much of the discussion.

Thumbnail

No more meaningful use? MedPAC floats idea in MACRA discussion

Physicians wouldn’t be measured on meaningful use of electronic health records (EHRs) in the new Merit-based Incentive Payment System (MIPS) under a proposal floated by the Medicare Payment Advisory Commission (MedPAC).

Thumbnail

HIMSS 2017: Ex-HHS Secretary Mike Leavitt predicts ‘less disruptive’ ACA repeal, survival of CMMI

The era of President Donald Trump in healthcare policy may not go as predicted, either for Republicans in Congress or Democrats critical of his pick for HHS Secretary, according to the last Republican who ran the agency, Mike Leavitt.

AHIMA releases toolkit to assist in preparing for HIPAA audits

The American Health Information Management Association (AHIMA) has released its External HIPAA Audit Readiness Toolkit to assist organizations in preparing for the upcoming Health Insurance Portability and Accountability Act (HIPAA) Phase 2 audits. The toolkit includes Phase 2 aspects for covered entities, business associates and includes tips in meeting responsibilities.

Displaying 4897 - 4904 of 6645

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup